Skip to main content
. 2022 Feb 11;12(7):3049–3062. doi: 10.1016/j.apsb.2022.02.002

Figure 2.

Figure 2

Structure‒tissue selectivity/exposure–activity relationship (STAR) selects better drug candidates and balances clinical dose/efficacy/toxicity to improve drug optimization for successful clinical drug development.